Evidence map›Paper›PMID 41592563›Full record

ArticleAmerican journal of human genetics2026

Dominant and recessive ATOH1 variants cause distinct neurodevelopmental disorders with hearing loss.

Nicole Bertola, Eléonore Blondiaux, Madeleine Harion, Imen Dorboz, Sandrine Passemard, Sandra Mercier, Solène Conrad, Benjamin Cogné, Julie Boyer, Sophie Uyttebroeck and 11 more

Abstract read
In one paragraph

Article in American journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Nicole BertolaDevelopmental Brain Disorders Laboratory, Institut Imagine, Université Paris Cité, INSERM, UMR 1163, 75015 Paris, France.
Eléonore BlondiauxDepartment of Pediatric Radiology, Hôpital Armand-Trousseau, GRC IMAGES, APHP, Sorbonne Université, 75012 Paris, France.
Madeleine HarionService de Neuropédiatrie, CRMR des malformations et maladies congénitales du cervelet, APHP, Sorbonne Université, Hôpital Armand-Trousseau, 75012 Paris, France; Faculté de Médecine, Sorbonne Université, 75013 Paris, France.
Imen DorbozService de Neurologie Pédiatrique, DMU INOV-RDB, APHP, Hôpital Robert Debré, 75019 Paris, France.
Sandrine PassemardService de Neurologie Pédiatrique, DMU INOV-RDB, APHP, Hôpital Robert Debré, 75019 Paris, France; Université Paris Cité, UMR 1141, INSERM, Hôpital Robert Debré, 75019 Paris, France.
Sandra MercierNantes Université, CHU de Nantes, Service de Génétique médicale, 44000 Nantes, France.
Solène ConradNantes Université, CHU de Nantes, Service de Génétique médicale, 44000 Nantes, France.
Benjamin CognéNantes Université, CHU de Nantes, Service de Génétique médicale, 44000 Nantes, France; Nantes Université, CHU de Nantes, CNRS, INSERM, l'Institut du thorax, 44000 Nantes, France.
Julie BoyerService d'ORL et chirurgie cervico-faciale, ORL pédiatrique, Centre Hospitalier Universitaire de Nantes, 44000 Nantes, France.
Sophie UyttebroeckVrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Clinical Sciences, Research Group Genetics, Reproduction and Development, Centre for Medical Genetics, 1090 Brussels, Belgium.
Kristof Van SchilCenter for Medical Genetics Antwerp, Antwerp University Hospital, 2650 Antwerp, Belgium.
Wim WuytsCenter for Medical Genetics Antwerp, Antwerp University Hospital, 2650 Antwerp, Belgium.
Nanna Dahl RendtorffDepartment of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.
Mette BertelsenDepartment of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.
Kristianna MeyDepartment of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark.
Pierre BlancLaboratoire SeqOIA, 75014 Paris, France.
Jerome ChampLaboratoire SeqOIA, 75014 Paris, France.
Odile Boespflug-TanguyService de Neurologie Pédiatrique, DMU INOV-RDB, APHP, Hôpital Robert Debré, 75019 Paris, France; Université Paris Cité, UMR 1141, INSERM, Hôpital Robert Debré, 75019 Paris, France.
Vincent CantagrelDevelopmental Brain Disorders Laboratory, Institut Imagine, Université Paris Cité, INSERM, UMR 1163, 75015 Paris, France.
Lydie BurglenDevelopmental Brain Disorders Laboratory, Institut Imagine, Université Paris Cité, INSERM, UMR 1163, 75015 Paris, France; Centre de référence des malformations et maladies congénitales du cervelet et Laboratoire de neurogénétique pédiatrique, Département de génétique, APHP, Sorbonne Université, Hôpital Armand-Trousseau, 75012 Paris, France. Electronic address: lydie.burglen@aphp.fr.
Marion CoolenDevelopmental Brain Disorders Laboratory, Institut Imagine, Université Paris Cité, INSERM, UMR 1163, 75015 Paris, France. Electronic address: marion.coolen@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ATOH1 encodes a basic helix-loop-helix transcription factor critical for hindbrain development and mechanosensory system formation. While animal models have provided extensive functional insights, few human disease-causing variants in ATOH1 have been reported and with no clear functional validation. Here, we report three heterozygous frameshift variants identified in five unrelated families, leading to C-ter truncations of ATOH1 and consistently associated with hearing loss, subtle motor impairments, and a highly recognizable pattern of brainstem malformations. Diffusion tensor imaging in two individuals further revealed reproducible anomalies in specific fiber tracts, supporting a convergent neuroanatomical signature. We also report an early-truncating variant, which, in contrast, is recessive and causes a distinct neurodevelopmental syndrome with highly severe cerebellar and pontine hypoplasia. Functional assays demonstrate that, unlike recessive variants, C-terminal truncating variants retain transcriptional activity but display increased protein stability. In vivo modeling using zebrafish showed that C-terminal truncations of atoh1a are sufficient to disrupt hindbrain neurogenesis and lateral-line hair cell specification. Furthermore, comparisons with loss-of-function phenotypes support a gain-of-function mechanism. Altogether, our findings establish that dominant and recessive ATOH1 variants give rise to different neurodevelopmental syndromes through distinct pathological mechanisms. Our work also underscores the importance of tight temporal control of transcription factor activity during hindbrain development and demonstrates how even subtle neurological phenotypes can arise from early disruption of core developmental programs.

Indexed as

Basic Helix-Loop-Helix ProteinsGenes, DominantGenes, RecessiveHearing LossNeurodevelopmental DisordersAnimalsCerebellumFemaleFrameshift MutationHumansMaleNeurogenesisPedigreePhenotypeRhombencephalonZebrafishBasic Helix-Loop-Helix ProteinsATOH1cerebellumhearing losshindbrain malformationmechanosensory hair cellsneurodevelopmental disorderprotein turnovertranscription factor

Identifiers

PMID41592563
PMCPMC13087419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.